Related references
Note: Only part of the references are listed.The role of innate immunity and inflammation in Parkinson′s disease
Maria Oberg et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2021)
Dysregulated autophagy is linked to BAX oligomerization and subsequent cytochrome c release in 6-hydroxydopmaine-treated neuronal cells
Yuhyun Chung et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Mechanistic insights into the protective effect of paracetamol against rotenone-induced Parkinson?s disease in rats: Possible role of endocannabinoid system modulation
Aya Yassin Labib et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
The dynamics of nigrostriatal system damage and neurobehavioral changes in the rotenone rat model of Parkinson's disease
Dmitry Troshev et al.
BRAIN RESEARCH BULLETIN (2021)
Neurological disorders and mitochondria
J. V. Cabral-Costa et al.
MOLECULAR ASPECTS OF MEDICINE (2020)
Protective effect of Diosmin against benzo(a)pyrene-induced lung injury in Swiss Albino Mice
Johirul Islam et al.
ENVIRONMENTAL TOXICOLOGY (2020)
Diosmin Treats Lipopolysaccharide-Induced Inflammatory Pain and Peritonitis by Blocking NF-κB Activation in Mice
Victor Fattori et al.
JOURNAL OF NATURAL PRODUCTS (2020)
Chronic Systemic Exposure to Low-Dose Rotenone Induced Central and Peripheral Neuropathology and Motor Deficits in Mice: Reproducible Animal Model of Parkinson's Disease
Ikuko Miyazaki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Diosmin ameliorates inflammation, insulin resistance, and fibrosis in an experimental model of non-alcoholic steatohepatitis in rats
Samar H. Gerges et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2020)
Neuroprotective Role of Diosmin on Rotenone Induced Neurotoxicity in SH-SY5Y Neuroblastoma Cells
Sridevi Balraj et al.
BIOSCIENCE BIOTECHNOLOGY RESEARCH COMMUNICATIONS (2020)
Diosmin ameliorative effects on oxidative stress and fibrosis in paraquat-induced lung injury in mice
Sirus Mirzaee et al.
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2019)
Balancing Apoptosis and Autophagy for Parkinson's Disease Therapy: Targeting BCL-2
Jia Liu et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Anti-inflammatory, antioxidant and anti-apoptotic activity of diosmin in acetic acid-induced ulcerative colitis
A. S. Shalkami et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2018)
Targeting Keap-1/Nrf-2 pathway and cytoglobin as a potential protective mechanism of diosmin and pentoxifylline against cholestatic liver cirrhosis
Fares E. M. Ali et al.
LIFE SCIENCES (2018)
Neuroprotective Effects of Filgrastim in Rotenone-Induced Parkinson's Disease in Rats: Insights into its Anti-Inflammatory, Neurotrophic, and Antiapoptotic Effects
Mariama S. Azmy et al.
MOLECULAR NEUROBIOLOGY (2018)
The Parkinson Pandemic-A Call to Action
E. Ray Dorsey et al.
JAMA NEUROLOGY (2018)
Diosmin is neuroprotective in a rat model of scopolamine-induced cognitive impairment
Sahreh Shabani et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Tetramethylpyrazine Ameliorates Rotenone-Induced Parkinson's Disease in Rats: Involvement of Its Anti-Inflammatory and Anti-Apoptotic Actions
Haidy E. Michel et al.
MOLECULAR NEUROBIOLOGY (2017)
Pathological α-synuclein exacerbates the progression of Parkinson's disease through microglial activation
Qiu-Shuang Zhang et al.
TOXICOLOGY LETTERS (2017)
Diosmin-induced senescence, apoptosis and autophagy in breast cancer cells of different p53 status and ERK activity
Anna Lewinska et al.
TOXICOLOGY LETTERS (2017)
Diosmin improved cognitive deficit and amplified brain electrical activity in the rat model of traumatic brain injury
Mohammad Ali Mirshekar et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Subcutaneous rotenone rat model of Parkinson's disease: Dose exploration study
Zhen-Nian Zhang et al.
BRAIN RESEARCH (2017)
Diosmin reduces cerebral Aβ levels, tau hyperphosphorylation, neuroinflammation, and cognitive impairment in the 3xTg-AD mice
Darrell Sawmiller et al.
JOURNAL OF NEUROIMMUNOLOGY (2016)
The rotenone-induced rat model of Parkinson's disease: Behavioral and electrophysiological findings
Christof von Wrangel et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
Neuroprotective effects of vildagliptin in rat rotenone Parkinson's disease model: role of RAGE-NFκB and Nrf2 antioxidant signaling pathways
Rania M. Abdelsalam et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Diosmin induces genotoxicity and apoptosis in DU145 prostate cancer cell line
Anna Lewinska et al.
TOXICOLOGY IN VITRO (2015)
Role of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative Diseases
Ronald Melki
JOURNAL OF PARKINSONS DISEASE (2015)
Insights into Neuroinflammation in Parkinson's Disease: From Biomarkers to Anti-Inflammatory Based Therapies
Natalia Pessoa Rocha et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Inhibition of Neuroinflammation and Mitochondrial Dysfunctions by Carbenoxolone in the Rotenone Model of Parkinson's Disease
Poonam Thakur et al.
MOLECULAR NEUROBIOLOGY (2015)
Diosmin Protects against Ethanol-Induced Gastric Injury in Rats: Novel Anti-Ulcer Actions
Hany H. Arab et al.
PLOS ONE (2015)
BAX channel activity mediates lysosomal disruption linked to Parkinson disease
Jordi Bove et al.
AUTOPHAGY (2014)
Water soluble binary and ternary complexes of diosmin with β-cyclodextrin: Spectroscopic characterization, release studies and anti-oxidant activity
Md Khalid Anwer et al.
JOURNAL OF MOLECULAR LIQUIDS (2014)
Synucleins Regulate the Kinetics of Synaptic Vesicle Endocytosis
Karina J. Vargas et al.
JOURNAL OF NEUROSCIENCE (2014)
DIOSMIN PROTECTS AGAINST CEREBRAL ISCHEMIA/REPERFUSION INJURY THROUGH ACTIVATING JAK2/STAT3 SIGNAL PATHWAY IN MICE
X. Liu et al.
NEUROSCIENCE (2014)
Diosmin protects against ethanol-induced hepatic injury via alleviation of inflammation and regulation of TNF-α and NF-κB activation
Mir Tahir et al.
ALCOHOL (2013)
Pathogenesis of Parkinson's Disease
Etienne C. Hirsch et al.
MOVEMENT DISORDERS (2013)
ANTI-INFLAMMATORY PROPERTIES RATHER THAN ANTI-OXIDANT CAPABILITY IS THE MAJOR MECHANISM OF NEUROPROTECTION BY SODIUM SALICYLATE IN A CHRONIC ROTENONE MODEL OF PARKINSON'S DISEASE
P. Thakur et al.
NEUROSCIENCE (2013)
Diosmin protects against TCE (trichloroethylene) induced renal injury in Wistar rats: Plausible role of p53, Bax and caspases
Muneeb U. Rehman et al.
TOXICOLOGY LETTERS (2013)
Limelight on Alpha-Synuclein: Pathological and Mechanistic Implications in Neurodegeneration
Pauline Wales et al.
JOURNAL OF PARKINSONS DISEASE (2013)
Classic and New Animal Models of Parkinson's Disease
Javier Blesa et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
NEUROTOXIN-BASED MODELS OF PARKINSON'S DISEASE
J. Bove et al.
NEUROSCIENCE (2012)
Mitochondrial Biology and Parkinson's Disease
Celine Perier et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Epidemiology and etiology of Parkinson's disease: a review of the evidence
Karin Wirdefeldt et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2011)
The effect of Ginkgo biloba extract on 3-nitropropionic acid-induced neurotoxicity in rats
Heba M. Mandy et al.
NEUROCHEMISTRY INTERNATIONAL (2011)
GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE: ACTIVITY INHIBITION AND PROTEIN OVEREXPRESSION IN ROTENONE MODELS FOR PARKINSON'S DISEASE
J. Huang et al.
NEUROSCIENCE (2011)
Edaravone Guards Dopamine Neurons in a Rotenone Model for Parkinson's Disease
Nian Xiong et al.
PLOS ONE (2011)
Mitochondrial dysfunction in Parkinson's disease
Konstanze F. Winklhofer et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
Inhibition of I kappa B Kinase-beta Protects Dopamine Neurons Against Lipopolysaccharide-Induced Neurotoxicity
Feng Zhang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro
Jacqueline Burre et al.
SCIENCE (2010)
Targets for neuroprotection in Parkinson's disease
Talene A. Yacoubian et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
David A. Price et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
The transcription factor Nrf2 as a new therapeutic target in Parkinson's disease
Antonio Cuadrado et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Flavonoid-mediated presenilin-1 phosphorylation reduces Alzheimer's disease β-amyloid production
Kavon Rezai-Zadeh et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
alpha-Synuclein Misfolding and Neurodegenerative Diseases
Vladimir N. Uversky
CURRENT PROTEIN & PEPTIDE SCIENCE (2008)
Cell systems and the toxic mechanism(s) of alpha-synuclein
Mark R. Cookson et al.
EXPERIMENTAL NEUROLOGY (2008)
Controlling the mass action of alpha-synuclein in Parkinson's disease
Changyoun Kim et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Protective effect of the green tea component, L-theanine on environmental toxins-induced neuronal cell death
Hong-Suk Cho et al.
NEUROTOXICOLOGY (2008)
Selective inhibition of NF-κB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease
Anamitra Ghosh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes
Mahendra Bishnoi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Herne oxygenase protects hippocampal neurons from ethanol-induced neurotoxicity
Bo Mi Ku et al.
NEUROSCIENCE LETTERS (2006)
Small Maf proteins serve as transcriptional cofactors for keratinocyte differentiation in the Keap1-Nrf2 regulatory pathway
H Motohashi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain
ALM Ferri et al.
DEVELOPMENT (2004)
Idiopathic Parkinson's disease:: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen
H Braak et al.
JOURNAL OF NEURAL TRANSMISSION (2003)
Activation of microglia by human neuromelanin is NF-kappa B-dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson's disease
H Wilms et al.
FASEB JOURNAL (2003)
Micronised purified flavonoid fraction - A review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids
KA Lyseng-Williamson et al.
DRUGS (2003)
An anti-Parkinson's disease drug, N-propargyl-1(R)-aminoindan (rasagiline), enhances expression of anti-apoptotic Bcl-2 in human dopaminergic SH-SY5Y cells
Y Akao et al.
NEUROSCIENCE LETTERS (2002)
Enhanced expression of iNOS intratumorally and at the immunization site after immunization with IFNγ-secreting rat glioma cells
AC Johansson et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Clinical benefits of daflon 500 mg in the most severe stages of chronic venous insufficiency
AA Ramelet
ANGIOLOGY (2001)
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
R Betarbet et al.
NATURE NEUROSCIENCE (2000)
Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions
BI Giasson et al.
SCIENCE (2000)
Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease
NA Tatton
EXPERIMENTAL NEUROLOGY (2000)
Genetic analysis of immunomodulating factors in sporadic Parkinson's disease
R Kruger et al.
JOURNAL OF NEURAL TRANSMISSION (2000)
Share Paper
